Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
Locametz 25 micrograms kit for radiopharmaceutical preparation.
| Pharmaceutical Form |
|---|
|
Kit for radiopharmaceutical preparation. One vial of white lyophilised powder (powder for solution for injection). |
The vial contains 25 micrograms of gozetotide.
The radionuclide is not part of the kit.
Excipient with known effect: The vial contains 28.97 mg of sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Gallium ⁶⁸Ga gozetotide |
|
| List of Excipients |
|---|
|
Gentisic acid |
Locametz is supplied as a multidose kit for the radiopharmaceutical preparation of gallium (68Ga) gozetotide solution for injection (see sections 2 and 3). Locametz contains one 10 mL type I Plus glass vial closed with a rubber stopper and sealed with a flip-off cap.
Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
EU/1/22/1692/001
| Drug | Countries | |
|---|---|---|
| LOCAMETZ | Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Romania, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
